| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| ERVK-6 |
|
endogenous retrovirus group K member 6, envelope
|
|
|
0.521 |
0.808 |
| ERVK-20 |
|
endogenous retrovirus group K member 20
|
|
|
0.533 |
0.692 |
| ERVK-32 |
|
endogenous retrovirus group K member 32, envelope
|
|
|
0.522 |
0.692 |
| GRAP2 |
O75791
|
GRB2 related adaptor protein 2
|
|
1.5E-04 |
0.394 |
0.923 |
| AHSA1 |
O95433
|
activator of HSP90 ATPase activity 1
|
|
1.00 |
0.396 |
0.923 |
| TIMP1 |
P01033
|
TIMP metallopeptidase inhibitor 1
|
Enzyme modulator
|
0.50 |
0.380 |
0.885 |
| MYC |
P01106
|
MYC proto-oncogene, bHLH transcription factor
|
Transcription factor
|
1.00 |
0.344 |
0.923 |
| TNF |
P01375
|
tumor necrosis factor
|
Signaling
|
0.80 |
0.231 |
0.962 |
| IFNB1 |
P01574
|
interferon beta 1
|
|
|
0.421 |
0.846 |
| IFNG |
P01579
|
interferon gamma
|
|
0.47 |
0.288 |
0.962 |
| IL1A |
P01583
|
interleukin 1 alpha
|
|
1.6E-04 |
0.333 |
0.962 |
| IL1B |
P01584
|
interleukin 1 beta
|
|
0.13 |
0.276 |
0.962 |
| EPO |
P01588
|
erythropoietin
|
|
1.1E-02 |
0.381 |
0.885 |
| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |
| MBP |
P02686
|
myelin basic protein
|
|
0.28 |
0.510 |
0.885 |
| CRP |
P02741
|
C-reactive protein
|
|
3.7E-03 |
0.299 |
0.962 |
| CXCL10 |
P02778
|
C-X-C motif chemokine ligand 10
|
Signaling
|
0.37 |
0.378 |
0.885 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
| TP53 |
P04637
|
tumor protein p53
|
Transcription factor
|
0.53 |
0.236 |
0.962 |
| IGF1 |
P05019
|
insulin like growth factor 1
|
|
0.27 |
0.318 |
0.885 |
| IL4 |
P05112
|
interleukin 4
|
|
4.7E-03 |
0.332 |
0.962 |
| IL5 |
P05113
|
interleukin 5
|
|
5.7E-03 |
0.437 |
0.846 |
| IL6 |
P05231
|
interleukin 6
|
|
0.32 |
0.248 |
0.962 |